Press Releases

Date	Title	Company
14-Apr-2022	One-step ELISA Market Insights, Deep Analysis of Key Vendor in the Industry 2018-2028	MARKITWIRED
14-Apr-2022	Late Stage Chronic Kidney Disease Therapeutics Market Current and Future Demand, Analysis, Growth and Forecast By 2028	MARKITWIRED
14-Apr-2022	Neurovascular Access Catheters Market Competitive Growth Strategies Based on Type, Applications, End User and Region	MARKITWIRED
14-Apr-2022	Antimicrobial Regenerative Wound Matrix Market One the Most Booming Industry in Upcoming Years Due to Global Demand in Industry by 2031	MARKITWIRED
14-Apr-2022	Moderna and Thermo Fisher Scientific Honored for COVID-19 Vaccine Efforts	Businesswire
14-Apr-2022	Labster Engages Learning Experience Design Research Team to Build K-12 ESSA Evidence Portfolio	Businesswire
14-Apr-2022	IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings	Businesswire
14-Apr-2022	Edgewise-Funded Natural History Trial of Becker Muscular Dystrophy (BMD) Now Enrolling	Businesswire
14-Apr-2022	Exelixis Announces Initiation of First-In-Human Phase 1 Trial Evaluating XL114 Monotherapy in Patients with Non-Hodgkin’s Lymphoma	Businesswire
14-Apr-2022	Magenta Therapeutics Focuses R&D and Operational Spending, Reduces Workforce and Extends Cash Runway	Businesswire
14-Apr-2022	World Animal Health Market Size, Share & Trends Analysis Report 2022-2030 - ResearchAndMarkets.com	Businesswire
14-Apr-2022	Global Cryostat Markets, 2022-2027 - Growing Demand in Aerospace Applications & Rising Use of Cryostats in MRI Machines - ResearchAndMarkets.com	Businesswire
14-Apr-2022	Marinus Pharmaceuticals Announces Publication in The Lancet Neurology of ZTALMY® (ganaxolone) Phase 3 Marigold Trial Results	Businesswire
14-Apr-2022	Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age	Businesswire
14-Apr-2022	Merck Announces U.S. FDA has Granted Breakthrough Therapy Designation for V116, the Company’s Investigational 21-Valent Pneumococcal Conjugate Vaccine, for the Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults	Businesswire
14-Apr-2022	Be Bio Closes $130 Million Financing to Pioneer Engineered B Cells, a New Class of Cellular Medicines	Businesswire
14-Apr-2022	Alzheon Appoints Susan Flint as Vice President of Clinical Operations, Patrick Kesslak, PhD, as Vice President of Clinical Development & Medical Affairs, and Erwan de Naurois as Vice President of Finance	Businesswire
14-Apr-2022	Global Dry Eye Products Markets Report 2022-2028: Ongoing Research and Growing Pipeline & Opportunities in Stem Cell Therapy - ResearchAndMarkets.com	Businesswire
14-Apr-2022	Original-Research: Formycon AG (von First Berlin Equity Research GmbH)	Formycon AG
14-Apr-2022	IR-Med Announces $3.2 Million Private Placement	Businesswire